Starling Oncology, Inc.: cash_and_equivalents
| Value | {"amount": 200000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2021-09-30) |
| Status | current |
| Entity | Starling Oncology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:08:36.054940+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a9d4667d-3913-4259-a4f1-6a9acde7119d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-21-135762Retrieved: 2026-08-19T18:08:36.054940+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001799191/cash-and-equivalents/2021-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a9d4667d-3913-4259-a4f1-6a9acde7119d
History
- no predecessors — first report